Matches in SemOpenAlex for { <https://semopenalex.org/work/W4223634396> ?p ?o ?g. }
- W4223634396 abstract "Several new biologic agents targeting IL23/Th17 axis, such as risankizumab, have been developed for the treatment of psoriasis. The aim of the present study was to analyze the efficacy and safety of risankizumab in patients with moderate-to-severe psoriasis over a 52-week period. A multicentric retrospective study was conducted in patients who initiated risankizumab between July 2019 and December 2020. Psoriasis Area and Severity Index-PASI was measured at baseline and after 4, 16, 28 and 52 weeks. Clinical responses were evaluated by PASI75, PASI90 and PASI100 at the same timepoints. Potential safety issues and adverse events (AEs) were collected. Univariable and multivariable logistic regressions were performed for variables predicting clinical response. One hundred and twelve patients with psoriasis were included. PASI90 response was achieved by 17.86% of patients at week 4, 72.22% at week 16, 91.0% at week 28 and 95.24% at week 52 (as observed analysis). No associations between the considered variables and the efficacy endpoints were retrieved, influence of variables such as Body Mass Index (BMI), baseline PASI or previous biologics were not shown. No serious safety issues or discontinuations related to adverse events were reported. Risankizumab showed high efficacy and a favorable safety profile, regardless of patient- and disease-related factors." @default.
- W4223634396 created "2022-04-15" @default.
- W4223634396 creator A5005493579 @default.
- W4223634396 creator A5015050981 @default.
- W4223634396 creator A5017909108 @default.
- W4223634396 creator A5018495576 @default.
- W4223634396 creator A5027650355 @default.
- W4223634396 creator A5030077978 @default.
- W4223634396 creator A5036093206 @default.
- W4223634396 creator A5041854258 @default.
- W4223634396 creator A5045083630 @default.
- W4223634396 creator A5049749332 @default.
- W4223634396 creator A5058362943 @default.
- W4223634396 creator A5061743711 @default.
- W4223634396 creator A5065547176 @default.
- W4223634396 creator A5073067783 @default.
- W4223634396 creator A5075659127 @default.
- W4223634396 creator A5077261955 @default.
- W4223634396 creator A5083362670 @default.
- W4223634396 creator A5084739387 @default.
- W4223634396 date "2022-04-13" @default.
- W4223634396 modified "2023-10-18" @default.
- W4223634396 title "Risankizumab for the treatment of moderate‐to‐severe psoriasis: A multicenter, retrospective, 1 year real‐life study" @default.
- W4223634396 cites W1796988553 @default.
- W4223634396 cites W1971708477 @default.
- W4223634396 cites W2003307133 @default.
- W4223634396 cites W2040737548 @default.
- W4223634396 cites W2061313701 @default.
- W4223634396 cites W2067327580 @default.
- W4223634396 cites W2158420662 @default.
- W4223634396 cites W2464558465 @default.
- W4223634396 cites W2765150986 @default.
- W4223634396 cites W2767948496 @default.
- W4223634396 cites W2783983416 @default.
- W4223634396 cites W2795371082 @default.
- W4223634396 cites W2887412253 @default.
- W4223634396 cites W2924895007 @default.
- W4223634396 cites W3016827639 @default.
- W4223634396 cites W3037060742 @default.
- W4223634396 cites W3048245109 @default.
- W4223634396 cites W3092092411 @default.
- W4223634396 cites W3094028421 @default.
- W4223634396 cites W3107651834 @default.
- W4223634396 cites W3127388240 @default.
- W4223634396 cites W3131268984 @default.
- W4223634396 cites W3136709547 @default.
- W4223634396 cites W3143775625 @default.
- W4223634396 cites W3164696742 @default.
- W4223634396 cites W3165262640 @default.
- W4223634396 cites W3173878348 @default.
- W4223634396 cites W3185249827 @default.
- W4223634396 cites W3199340815 @default.
- W4223634396 cites W3204010602 @default.
- W4223634396 cites W4223634396 @default.
- W4223634396 doi "https://doi.org/10.1111/dth.15489" @default.
- W4223634396 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35385202" @default.
- W4223634396 hasPublicationYear "2022" @default.
- W4223634396 type Work @default.
- W4223634396 citedByCount "11" @default.
- W4223634396 countsByYear W42236343962022 @default.
- W4223634396 countsByYear W42236343962023 @default.
- W4223634396 crossrefType "journal-article" @default.
- W4223634396 hasAuthorship W4223634396A5005493579 @default.
- W4223634396 hasAuthorship W4223634396A5015050981 @default.
- W4223634396 hasAuthorship W4223634396A5017909108 @default.
- W4223634396 hasAuthorship W4223634396A5018495576 @default.
- W4223634396 hasAuthorship W4223634396A5027650355 @default.
- W4223634396 hasAuthorship W4223634396A5030077978 @default.
- W4223634396 hasAuthorship W4223634396A5036093206 @default.
- W4223634396 hasAuthorship W4223634396A5041854258 @default.
- W4223634396 hasAuthorship W4223634396A5045083630 @default.
- W4223634396 hasAuthorship W4223634396A5049749332 @default.
- W4223634396 hasAuthorship W4223634396A5058362943 @default.
- W4223634396 hasAuthorship W4223634396A5061743711 @default.
- W4223634396 hasAuthorship W4223634396A5065547176 @default.
- W4223634396 hasAuthorship W4223634396A5073067783 @default.
- W4223634396 hasAuthorship W4223634396A5075659127 @default.
- W4223634396 hasAuthorship W4223634396A5077261955 @default.
- W4223634396 hasAuthorship W4223634396A5083362670 @default.
- W4223634396 hasAuthorship W4223634396A5084739387 @default.
- W4223634396 hasBestOaLocation W42236343962 @default.
- W4223634396 hasConcept C126322002 @default.
- W4223634396 hasConcept C16005928 @default.
- W4223634396 hasConcept C167135981 @default.
- W4223634396 hasConcept C197934379 @default.
- W4223634396 hasConcept C2777011040 @default.
- W4223634396 hasConcept C2780221984 @default.
- W4223634396 hasConcept C2780564577 @default.
- W4223634396 hasConcept C30036603 @default.
- W4223634396 hasConcept C71924100 @default.
- W4223634396 hasConceptScore W4223634396C126322002 @default.
- W4223634396 hasConceptScore W4223634396C16005928 @default.
- W4223634396 hasConceptScore W4223634396C167135981 @default.
- W4223634396 hasConceptScore W4223634396C197934379 @default.
- W4223634396 hasConceptScore W4223634396C2777011040 @default.
- W4223634396 hasConceptScore W4223634396C2780221984 @default.
- W4223634396 hasConceptScore W4223634396C2780564577 @default.
- W4223634396 hasConceptScore W4223634396C30036603 @default.
- W4223634396 hasConceptScore W4223634396C71924100 @default.
- W4223634396 hasIssue "6" @default.